NEROCARE CAPSAICIN NEUROPATHY RELIEF CREAM- capsaicin cream

Drug Labeling and Warnings

Drug Details [pdf]

ACTIVE INGREDIENT

CAPSAICIN 0.1%

PURPOSE

EXTERNAL ANALGESIC

INDICATIONS & USAGE

Effectively alleviatelocal neuralgia

WARNINGS

For external use only.

DO NOT USE

Do not use in or contact with eyes.

Do not apply to wounds or damagedskin.

PREGNANCY OR BREAST FEEDING

Do not use it if pregnant or breastfeeding.

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children unless under adult supervision.

lf swallowed, get medical help or contact a Poison Control Center right away.

INACTIVE INGREDIENT

INACTIVE INGREDIENTS:

GLYCERIN, WATER, MINERAL OIL, BUTYROSPERMUM PARKII (SHEA) BUTTER, DIMETHICONE, CETEARYL ALCOHOL, GLYCERYL STEARATE, PHENOXYETHANOL, PEG-100 STEARATE, POLYACRYLAMIDE, METHYLPARABEN, C13-14 ISOPARAFIN, MENTHYL LACTATE, BHT, ALLANTOIN, DIMETHICONOL, LAURETH-7, FRAGRANCE, DISODIUM EDTA, XANTHAN GUM, BUTYLENE GLYCOL, ARNICA MONTANA FLOWER EXTRACT, 1,2-HEXANEDIOL, HYDROXYACETOPHENONE

DOSAGE & ADMINISTRATION

Directions:
1.Clean and dry skin.
2.Apply an appropriate amount evenly toaffected areas such as your back,neck,knees,hips,shoulders and elbows,

3.Massage gently until absorbed.

4.Allow the area to dry naturally after application

5.Apply a small amount of the product tothe affected area 2-3 times daily.

OTHER SAFETY INFORMATION

Storage:

1.Please seal the product and store it in acool,dry place away from direct sunlight,

2.Do not store it in damp or high,temperatureenvironments like bathrooms,kitchens,or refrigerators.

3.Keep it out of children's reach,lftheproduct changes in characteristics(eg:oil separation or abnormal odor)discontinue use.

QUESTIONS

Email:support@nerocare.store

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

NEROCARE CAPSAICIN NEUROPATHY RELIEF CREAM 
capsaicin cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 84066-108
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
CAPSAICIN (UNII: S07O44R1ZM) (CAPSAICIN - UNII:S07O44R1ZM)	CAPSAICIN	0.1 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
PHENOXYETHANOL (UNII: HIE492ZZ3T)
METHYLPARABEN (UNII: A2I8C7HI9T)
ALLANTOIN (UNII: 344S277G0Z)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
C13-14 ISOPARAFFIN (UNII: E4F12ROE70)
POLYACRYLAMIDE (1500 MW) (UNII: 5D6TC4BRWV)
EDETATE DISODIUM (UNII: 7FLD91C86K)
GLYCERIN (UNII: PDC6A3C0OX)
MINERAL OIL (UNII: T5L8T28FGP)
DIMETHICONE (UNII: 92RU3N3Y1O)
MENTHYL LACTATE (UNII: 2BF9E65L7I)
WATER (UNII: 059QF0KO0R)
GLYCERYL STEARATE (UNII: 230OU9XXE4)
LAURETH-7 (UNII: Z95S6G8201)
ARNICA MONTANA FLOWER (UNII: OZ0E5Y15PZ)
BHT (UNII: 1P9D0Z171K)
CETEARYL ALCOHOL (UNII: 2DMT128M1S)
1,2-HEXANEDIOL (UNII: TR046Y3K1G)
XANTHAN GUM (UNII: TTV12P4NEE)
BUTYROSPERMUM PARKII (SHEA) BUTTER (UNII: K49155WL9Y)
PEG-100 STEARATE (UNII: YD01N1999R)
DIMETHICONOL (40 CST) (UNII: 343C7U75XW)
HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 84066-108-01	100 g in 1 TUBE; Type 0: Not a Combination Product	04/03/2026

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M017	04/03/2026

Labeler - Guangzhou Tata Biotechnology Co., Ltd. (699605102)